(Q38125386)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23900355%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

Dilated cardiomyopathy: the complexity of a diverse genetic architecture (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23900355%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

main subject

dilated cardiomyopathy

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23900355%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Dale J Hedges

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23900355%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Ana Morales

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23900355%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

language of work or name

English

0 references

publication date

30 July 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23900355%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Cardiology

6 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23900355%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23900355%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23900355%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

531-547

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23900355%20AND%20SRC:MED&resulttype=core&format=json

Clinical and genetic issues in familial dilated cardiomyopathy

6 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Clinical and genetic issues in dilated cardiomyopathy: a review for genetics professionals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Genetics of dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

31 March 2020

Dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

The genetics of dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Genetics of inherited cardiomyopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Where genome meets phenome: rationale for integrating genetic and protein biomarkers in the diagnosis and management of dilated cardiomyopathy and heart failure.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Clinical utility gene card for: dilated cardiomyopathy (CMD).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Phenomics: the next challenge

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Next-generation DNA sequencing, regulation, and the limits of paternalism: the next challenge

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Molecular diagnostics of cardiomyopathies: the future is here.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Genetic testing for dilated cardiomyopathy in clinical practice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Inherited cardiomyopathies: molecular genetics and clinical genetic testing in the postgenomic era.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Action and the actionability in exome variation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Clinical course of hypertrophic cardiomyopathy in a regional United States cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Family history of dilated cardiomyopathy among patients with heart failure from the HF-ACTION genetic ancillary study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Natural history of asymptomatic left ventricular systolic dysfunction in the community

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Prognosis of individuals with asymptomatic left ventricular systolic dysfunction in the multi-ethnic study of atherosclerosis (MESA).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

The importance of the family history in caring for families with long QT syndrome and dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

The Frequency of Familial Dilated Cardiomyopathy in a Series of Patients with Idiopathic Dilated Cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Temporal relationship of conduction system disease and ventricular dysfunction in LMNA cardiomyopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Truncations of titin causing dilated cardiomyopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Exome sequencing and genome-wide linkage analysis in 17 families illustrate the complex contribution of TTN truncating variants to dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Cardiac structural and sarcomere genes associated with cardiomyopathy exhibit marked intolerance of genetic variation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Evaluating pathogenicity of rare variants from dilated cardiomyopathy in the exome era.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Population-based variation in cardiomyopathy genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

LMNA cardiomyopathy: cell biology and genetics meet clinical medicine.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Burden of rare sarcomere gene variants in the Framingham and Jackson Heart Study cohorts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and p53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriers.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Hemochromatosis and iron-overload screening in a racially diverse population.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Next-generation sequencing to identify genetic causes of cardiomyopathies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Racial differences in incident heart failure among young adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Targeted next-generation sequencing can replace Sanger sequencing in clinical diagnostics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Update 2011: clinical and genetic issues in familial dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Evolution and functional impact of rare coding variation from deep sequencing of human exomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Single-nucleotide evolutionary constraint scores highlight disease-causing mutations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

SIFT: Predicting amino acid changes that affect protein function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Predicting functional effect of human missense mutations using PolyPhen-2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Actin mutations in dilated cardiomyopathy, a heritable form of heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Prevalence of Desmin Mutations in Dilated Cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Mutations in the muscle LIM protein and α-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Mutations in the ANKRD1 gene encoding CARP are responsible for human dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Coding sequence mutations identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 patients with familial or idiopathic dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Novel mutations in sarcomeric protein genes in dilated cardiomyopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

A glimpse into multigene rare variant genetics: triple mutations in hypertrophic cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Mutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Mutations in the Z-band protein myopalladin gene and idiopathic dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Coding sequence rare variants identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 from 312 patients with familial or idiopathic dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Novel mutation in cardiac troponin I in recessive idiopathic dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Identification and functional characterization of cardiac troponin I as a novel disease gene in autosomal dominant dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Novel cardiac troponin T mutation as a cause of familial dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

The role of sarcomere gene mutations in patients with idiopathic dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Identification of a novel frameshift mutation in the giant muscle filament titin in a large Australian family with dilated cardiomyopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Epidemiology of desmin and cardiac actin gene mutations in a european population of dilated cardiomyopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Desmin mutation responsible for idiopathic dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Laminin-alpha4 and integrin-linked kinase mutations cause human cardiomyopathy via simultaneous defects in cardiomyocytes and endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Mutations in PDLIM3 and MYOZ1 encoding myocyte Z line proteins are infrequently found in idiopathic dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

A novel mutation, Arg71Thr, in the ?-sarcoglycan gene is associated with dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Mutational analysis of the beta- and delta-sarcoglycan genes in a large number of patients with familial and sporadic dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Metavinculin mutations alter actin interaction in dilated cardiomyopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Lamin A/C Gene Mutation Associated With Dilated Cardiomyopathy With Variable Skeletal Muscle Involvement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

High Incidence of Sudden Death with Conduction System and Myocardial Disease Due to Lamins A and C Gene Mutation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Novel lamin A/C mutations in two families with dilated cardiomyopathy and conduction system disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

A novel lamin A/C mutation in a family with dilated cardiomyopathy, prominent conduction system disease, and need for permanent pacemaker implantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Natural history of dilated cardiomyopathy due to lamin A/C gene mutations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Lamin A/C truncation in dilated cardiomyopathy with conduction disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

A new locus for autosomal dominant dilated cardiomyopathy identified on chromosome 6q12-q16

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

LMNA mutations in cardiac transplant recipients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Novel mutations in the lamin A/C gene in heart transplant recipients with end stage dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Mutations of presenilin genes in dilated cardiomyopathy and heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Sodium channel mutations and susceptibility to heart failure and atrial fibrillation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

A novel X-linked gene, G4.5. is responsible for Barth syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Identification of novel mutations in RBM20 in patients with dilated cardiomyopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Phospholamban R14 deletion results in late-onset, mild, hereditary dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Mutational screening of phospholamban gene in hypertrophic and idiopathic dilated cardiomyopathy and functional study of the PLN -42 C>G mutation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Desmosomal protein gene mutations in patients with idiopathic dilated cardiomyopathy undergoing cardiac transplantation: a clinicopathological study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Alpha B-crystallin mutation in dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Mutation in the transcriptional coactivator EYA4 causes dilated cardiomyopathy and sensorineural hearing loss

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Clinical and functional characterization of TNNT2 mutations identified in patients with dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2013.105

Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23900355

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Genetic testing in cardiovascular medicine: current landscape and future horizons.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23900355

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Black-white differences in mortality in idiopathic dilated cardiomyopathy: the Washington, DC, dilated cardiomyopathy study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23900355

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRCARDIO.2013.105

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23900355%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference